Thus in addition to anomalies frequently observed in oxidative phosphorylation defects, patients with UQCRC2 defects could also have some abnormalities that are less characteristic, including hypoglycemia and hyperammonemia. This evidence concerns the gene UQCRC2 and Hyperammonemia.